UCLA is hosting its first-ever cannabis research symposium April 20, from 8 a.m. to 4 p.m., at the Neuroscience Research Building Auditorium.
With the recent passage of Proposition 64, the Adult Use of Marijuana Act, California became the largest U.S. market for legal marijuana. Moreover, 20% of the U.S population now has access to legal recreational cannabis, 60% has access to legal medical cannabis, and over 90% has access to some form of legal cannabis product. Despite this unprecedented access to legal cannabis, research about the risks and therapeutic potential of marijuana is lacking.
The symposium, sponsored by the UCLA Brain Research Institute and the Semel Institute, will feature visiting speakers and UCLA faculty on the science regarding cannabis, cannabinoids and the endocannnabinoid system. Topics will include cannabinoids for chronic pain and pediatric epilepsy, as well as psychiatric and pulmonary effects.
The event is free, but registration is required. You can find more information here.
